Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls (2021)
Source: New england journal of medicine. Unidade: FM
Subjects: ATROFIA MUSCULAR, MEDULA ESPINHAL, LACTENTES, COMPOSTOS ORGÂNICOS, COMPOSTOS HETEROCÍCLICOS, ÍNDICE DE GRAVIDADE DA DOENÇA
ABNT
DARRAS, Basil T. et al. Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls. New england journal of medicine, v. 385, n. 5, p. 427-435, 2021Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa2102047. Acesso em: 19 abr. 2024.APA
Darras, B. T., Masson, R., Mazurkiewicz-beldzinska, M., Rose, K., Xiong, H., Zanoteli, E., et al. (2021). Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls. New england journal of medicine, 385( 5), 427-435. doi:10.1056/NEJMoa2102047NLM
Darras BT, Masson R, Mazurkiewicz-beldzinska M, Rose K, Xiong H, Zanoteli E, Baranello G, Bruno C, Vlodavets D, Wang Y. Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls [Internet]. New england journal of medicine. 2021 ; 385( 5): 427-435.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1056/NEJMoa2102047Vancouver
Darras BT, Masson R, Mazurkiewicz-beldzinska M, Rose K, Xiong H, Zanoteli E, Baranello G, Bruno C, Vlodavets D, Wang Y. Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls [Internet]. New england journal of medicine. 2021 ; 385( 5): 427-435.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1056/NEJMoa2102047